ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2021 > Certificate of Competence in Breast Cancer - fourth cohort (CCB4)
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Certificate of Competence in Breast Cancer - fourth cohort (CCB4)

04.05.2021  -  23.07.2022



Breast cancer


Block 1 - 04.05.2021 / 08.05.2021 - Virtual

CCB4: Seminar 1 + ESMO Breast

Block 2 - 10.05.2021 / 31.07.2021 - Online Module

CCB4: Module 1: Epidemiology and prevention, biology and clinical trials

Block 3 - 01.08.2021 / 30.09.2021 - Online

CCB4: Module 2: Principles of diagnostics, DCIS, gene predisposition

Block 4 - 01.10.2021 / 30.11.2021 - Online

CCB4: Module 3: The breast unit and LABC

Block 5 - 03.11.2021 / 06.11.2021 - Virtual

CCB4: Seminar 2 + ABC6

Block 6 - 01.12.2021 / 15.03.2022 - Online

CCB4: Module 4: Management of early breast cancer

Block 7 - 15.03.2022 / 30.06.2022 - Online

CCB4: Module 5: Management of advanced breast cancer, male breast cancer and supportive therapies

Block 8 - 19.07.2022 / 23.07.2022 - Ulm, Germany

CCB4: Seminar 3


Stefan Aebi, Lucerne Cantonal Hospital, Dept. of Medical Oncology, Lucerne, CH
Vincenzo Bagnardi, Milan University, Dept. of Statistics ansd Quantative Methodology, Milan, IT
Adam Brentnall, Queen Mary University of London, Wolfson Institute of Preventative Medicine, Centre for Cancer Prevention, London, UK
Marc Buyse, IDDI & CluePoints, ., Louvain-la-Neuve, BE
Julia Camps Herrero, Hospital de la Ribera, Dept. of Radiology, Alzira, ES
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, PT
Francesca Caumo, Istituto Oncologico Veneto, Imaging Dpt., Padova, IT
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Jack Cuzick, Queen Mary University of London, Wolfson Institute of Preventive Medicine, Centre for Cancer Prevention, London, UK
Dragana Djilas, Oncology Institute of Vojvodina, Diagnostic Imaging Centre, Sremska Kamenica, RS
Matthew J. Ellis, Lester and Sue Smith Breast Center, Baylor Clinic, Houston, US
Alexandru Eniu, Riviera-Chablais Vaud-Valais, Interdisciplinary Oncology Service, Rennaz, CH
Tanja Gagliardi, Royal Marsden Hospital, Radiology Dpt., London, UK
Oreste Davide Gentilini, IRCCS Ospedale San Raffaele, Breast Surgery Dpt., Milano, IT
Roger Gomis, Institute for Research in Biomedicine, Growth Control and Cancer Metastasis Programme, Barcelona, ES
Richard Gray, University of Oxford, Nuffield Dept. of Population Health, Oxford, UK
Helen Hanson, St Georges NHS Foundation Trust, South West Thames Regional Genetics Service, London, UK
Anita Hiltbrunner, IBCSG/ETOP, Director, Bern, CH
Nehmat Houssami, University of Sydney, Sydney Medical School, Sydney, AU
Jens Huober, Ulm University Medical Center, Dept. of Obstetrics and Gynecology, Ulm, DE
J. Wolfgang Janni, Ulm University Medical Center, Dept. of Obstetrics and Gynecology, Ulm, DE
Youlia Kirova, Institut Curie, Radiation Oncology Dpt., Paris, FR
David Krug, University Hospital Schleswig-Holstein (UKSH), Radiation Oncology Dpt., Kiel, DE
Lorenza Marotti, EUSOMA - European Society of Breast Cancer Specialists, Oncology Dpt., Firenze, IT
John Martens, Erasmus MC, Dept. of Oncology, Rotterdam, NL
Laura Martincich, Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia, Radiology Dpt., Torino, IT
Liv Meert, EORTC, Data Management Dept., Brussels, BE
Olivia Pagani, Hopital Riviera Chablais, Service interdisciplinaire de cancérologie - SIC Center, Rennaz, CH
Pietro Panizza, Segrate, IT
Klaus Pantel, University Medical Center Hamburg-Eppendorf, Institute of Tumor Biology, Hamburg, DE
Lorenzo Patocchi, Cryms, DEV, Lamone, CH
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Emad Rakha, University of Nottingham and NUH NHS Trust, Dept. of Histopathology, Nottingham, UK
Peter Riegman, Erasmus MC, Pathology Department, Rotterdam, NL
Matti Rookus, Netherlands Cancer Institute, Dept. of Epidemiology, Amsterdam, NL
Isabel T. Rubio, Clínica Universidad de Navarra, Breast Surgical Oncology Dpt., Madrid, ES
Hope S. Rugo, UCSF Helen Diller Family CCC, Breast Oncology Clinical Trials Education, San Francisco, US
Uta Schmidt-Strassburger, Ulm University, Learning and Teaching, Medical Faculty, Ulm, DE
Elzbieta Senkus, Medical University of Gdansk, Dept. of Oncology and Radiotherapy, Gdansk, PL
Ivana Sestak, Queen Mary University of London, Wolfson Institute of Preventative Medicine, Centre for Cancer Prevention, London, UK
Christoph Thomssen, Martin Luther University Halle-Wittenburg, Dept. of Gynaecology, 06120 Halle, DE
Mangesh Thorat, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Dept. of Cancer Prevention, London, UK
Tibor Tot, Dalarna Region County Hospital, Dept of Pathology and Cytology, Falun, SE
Steven van Laere, University of Antwerp, CORE, Antwerp, BE
Didier Verhoeven, AZ Klina, Dept. of Oncology, Brasschaat, Antwerpen, BE
Lynda Wyld, University of Sheffield, Dept. of Oncology, Sheffield, UK